Kiora Pharmaceuticals Inc. sell Amped
Start price
28.07.21
/
0%
€108.80
Target price
28.07.22
-
Performance (%)
-94.78%
End price
29.07.22
€5.68
Summary
This prediction ended on 29.07.22 with a price of €5.68. The SELL prediction by Amped for Kiora Pharmaceuticals Inc. performed very well with a performance of -94.78%. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kiora Pharmaceuticals Inc. | -3.953% | -3.953% | -79.978% |
| iShares Core DAX® | 4.015% | 2.971% | 16.492% |
| iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% |
| iShares Nikkei 225® | -0.826% | -5.057% | 14.566% |
| iShares S&P 500 | 2.330% | 0.720% | 30.194% |
According to Amped what are the pros and cons of Kiora Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Known brand
Cons
High valuation
Sustainability is little important
high free float
Significant cyclical dependencies
Below average Management
Revenue decline/stagnation expected
Comments by Amped for this prediction
In the thread Kiora Pharmaceuticals Inc. diskutieren
Sell Eyegate Pharmaceuticals Inc.
In the thread Trading Kiora Pharmaceuticals Inc.
Die von Amped gewählte maximale Laufzeit wurde überschritten